Medicine and Dentistry
Wart Virus
100%
Uterine Cervix Carcinoma
76%
Human Papillomavirus Type 16
76%
Lopinavir
68%
Human Immunodeficiency Virus
60%
Carcinoma Cell
57%
Infection
49%
Uterine Cervix Cytology
48%
Human Immunodeficiency Virus Proteinase Inhibitor
43%
Protein P53
42%
Virus Infection
38%
In Vitro
36%
Diseases
35%
Malignant Neoplasm
33%
Cytotechnology
30%
Dysplasia
28%
Upregulation
26%
Promoter Region
26%
Indinavir
25%
Cervical Cancer
24%
Programmed Cell Death
22%
Gap Junction
19%
Hypoxia
19%
Head and Neck Carcinoma
19%
Prevalence
19%
Endothelial Cell
19%
Y-27632
19%
Cidofovir
19%
Lopinavir/Ritonavir
19%
Aciclovir
19%
Human T-Lymphotropic Virus 1
19%
Endogenous Retrovirus
19%
Serine Proteinase Inhibitor
19%
Arm
19%
Adverse Event
19%
T Cell
19%
Cancer Cell
19%
JC Virus
19%
Zinc Finger Protein
19%
Xenotropic MuLV Related Virus
19%
Investigational Drug
19%
Somatics
19%
Antiviral Protein
19%
Ribonuclease L
19%
Colposcopy
19%
Radiosensitivity
19%
Non-Transformed Cell
15%
Proteasome
14%
Cervix
12%
Keratinocyte
12%
Immunology and Microbiology
Human Papillomavirus Type 16
81%
Wart Virus
69%
Carcinoma Cell
64%
Human Immunodeficiency Virus
57%
Human T-Lymphotropic Virus 1
51%
Murine
28%
Squamous Cell
28%
Downregulation
25%
Human Papillomavirus Type 6
25%
P53
25%
Cell Line
22%
Vaccination Policy
21%
Neck
19%
CXCR3
19%
Human Papillomavirus Type 11
19%
Human Papillomavirus Related Disease
19%
Angiogenesis
19%
Keratinocyte
19%
Cell Surface
19%
Growth Factor
19%
Genotype
19%
Granzyme B
19%
Vaccine Efficacy
19%
Interleukin 3
19%
Myeloid Differentiation
19%
Prevalence
19%
Tumor Cell
19%
DNA Binding
19%
Stem Cell Line
19%
Xenotropic MuLV Related Virus
19%
Promoter Region
16%
Cell Fractionation
12%
Gene Expression
12%
Caspase
12%
Liquid Chromatography Mass Spectrometry
12%
Carboxy Terminal Sequence
12%
Upregulation
12%
Cellular Distribution
12%
Leukocyte
11%
Overall Survival
10%
Thymocyte
9%
Ovarian Cancer Cell Line
9%
Papillomaviridae
9%
in Situ Hybridization
9%
DNA Library
9%
Mast Cell Line
9%
Erythroid Cell
9%
Northern Blotting
9%
Stable Transfection
9%
Ovarian Carcinoma Cell Line
9%
Biochemistry, Genetics and Molecular Biology
Human Papillomavirus Type 16
51%
Human T-Lymphotropic Virus 1
44%
HIV Protease Inhibitor
38%
Angiogenesis
28%
Human Immunodeficiency Virus
28%
Metabolite
25%
Plexin
25%
Promoter Region
25%
Liquid Chromatography-Mass Spectrometry
22%
Wart Virus
21%
Binding Protein
19%
Serpin
19%
Syncytin
19%
Metabolomics
19%
Prevalence
19%
Gene Mutation
19%
P16
19%
Metabolome
19%
MACF1
19%
Human Papillomavirus Type 11
19%
TP63
19%
Heparanase
19%
Cell Invasion
19%
CXCR3
19%
RAC1
19%
Monospecific Antibody
19%
Xenotropic MuLV Related Virus
19%
Endogenous Retrovirus
19%
DNA Binding
19%
P53
16%
Messenger RNA
15%
C-Terminus
15%
Cell Fractionation
12%
Gene Expression
12%
Upregulation
12%
Fibroblast
12%
Nucleic Acid
12%
Subcellular Localization
12%
Drug Concentration
9%
Gas Chromatography
9%
Time-of-Flight Mass Spectrometry
9%
Ultra High Performance Liquid Chromatography
9%
Mass Spectrometry
9%
Drug Sensitivity
9%
Antisense
8%
G1 Phase
6%
Bcl-2
6%
Eicosanoid Receptor
6%
Cyclin D1
6%
Cyclin-Dependent Kinase
6%